Diabetes drug approved
The Scottish Medicines Consortium has approved the drug sitagliptin/metformin (Janumet) as an adjunct to diet and exercise to improve glycaemic control in patients with type 2 diabetes.
The drug is approved for patients inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of sitagliptin and metformin.
Online training units, written and reviewed by experts. Earn two hours' CPD and a personalised certificate for your portfolio.
Subscribers get FREE unlimited access to all our online learning units and non-subscribers can access each learning unit for £10 + VAT.